Genta (GNTA) Announces Initial Clinical Trial Results for G4544, a Novel Potent Drug for Bone Disease
Tweet Send to a Friend
Genta Incorporated (OTCBB: GNTA) announced the release of final results from the Company's Phase 1 clinical trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
